[Treatment of inappropriate TSH secretion with Triac].
Diagnostically one differentiates neoplastic and non neoplastic forms of inappropriate TSH-secretion characterized by increased TSH levels with a parallel rise in peripheral thyroid hormone parameters. Surgery is the treatment of choice in cases of TSH secreting pituitary tumors. In this paper different regims of medication are described in a patient with non neoplastic inappropriate TSH secretion. This 39-year-old woman underwent unsuccessful therapy both with bromocriptine and d-thyroxine. Finally a persistent (so far 4 months) TSH-suppression treatment with TRIAC brought lasting success to the same patient.
D000328:Adult; D005260:Female; D006044:Goiter, Nodular / Q000188:drug therapy; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy*; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood*; D014284:Triiodothyronine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014284:Triiodothyronine; C010642:3,3',5-triiodothyroacetic acid; D013972:Thyrotropin
Behandlung der inappropriaten TSH-Inkretion mit TRIAC.